Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial

Overview of attention for article published in Orphanet Journal of Rare Diseases, March 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 71 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,881 followers.

Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial. https://t.co/ECHKlNMOL6

29 Mar 2018

Reply Repost Favourite

Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial https://t.co/pasn6fEYhe

28 Mar 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.